Skip to main content

Table 1 The patient demographic data and the dose of insulin for 101 type 1 diabetic patients on basal-bolus insulin therapy as stratified equally by HbA1c value

From: The relationship between HbA1c values and the occurrence of hypoglycemia as assessed by continuous glucose monitoring in patients with type 1 diabetes

HbA1c

Group A

HbA1c ≤7.2 %

Group B

7.2 % <HbA1c ≤8.2 %

Group C

8.2 % <HbA1c ≤9.2 %

Group D

HbA1c >9.2 %

P value

Males

/femalesa

5/19

8/18

10/17

9/15

0.518

Age

(years)b

36.5

(32.0–58.8)

41.5

(31.5–54.5)

41.0

(32.0–55.0)

42.0

(35.0–57.8)

0.956

Duration of diabetes

(years)b

11.0

(5.3–30.0)

15.0

(7.8–25.5)

15.0

(5.0–24.0)

10.5

(7.3–15.0)

0.653

BMI

(kg/m2)b

20.3

(18.2–22.3)

22.6

(21.0–24.9)

22.4

(20.0–23.8)

22.2

(20.3–25.3)

0.007

U-CPR

(µg/day)b

1.2

(0.9–3.9)

0.9

(0.6–2.6)

1.3

(0.7–3.6)

1.0

(0.5–6.0)

0.622

Total daily dose of insulin (units)b

31.0

(25.5–38.8)

35.0

(26.5–41.5)

37.0

(29.0–46.0)

39.0

(31.3–51.5)

0.099

Basal insulin dose (units)b

13.5

(9.3–19.5)

14.0

(10.0–20.3)

15.0

(12.0–18.0)

18.5

(14.0–24.8)

0.021

Bolus insulin dose (units)b

17.0

(15.0–24.0)

19.5

(15.0–24.3)

20.0

(16.0–30.0)

21.5

(13.8–27.5)

0.296

  1. Data presented as median (25–75 percentiles)
  2. Italic values indicate significance of P value (P < 0.05)
  3. aChi square test
  4. bKruskal–Wallis test